Ovid Therapeutics Inc. (OVID) has a market capitalization of $447.05M and trades at $2.96. The 52-week range is 0.243-2.72.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -12.3, Earnings Per Share (EPS) of $-0.24, annual revenue of $7.25M.
The stock has a beta of -0.03, operates in the Healthcare sector.
